CHOREO, LLC

Position in NVO — Novo Nordisk A S

CIK 1679031 ROCKFORD, IL

Position in NVO

as of Jun 30, 2026 · filed Aug 4, 2026 Compact

Position Value

$5,824,038

+$1,898,403 QoQ

Shares Held

121,486

+13.7% QoQ

Ownership

0.003%

of shares outstanding

% of Portfolio

0.14%

of 13F equity value

Holder Rank

#197

of 1,348 holders

Holding Since

Mar 2023

14 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

CHOREO, LLC holds $158,372,063 across 15 Drug Manufacturers - General names. NVO ranks #8 (3.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	29,798	$35,740,618
2	JNJ	Johnson & Johnson	140,570	$35,700,562
3	ABBV	AbbVie Inc.	105,320	$26,502,724
4	MRK	Merck & Co., Inc.	129,070	$16,585,495
5	BMY	Bristol Myers Squibb Co	128,422	$7,399,675
6	AMGN	Amgen Inc	18,320	$6,634,038
7	NVS	Novartis AG	39,193	$6,142,326
8	NVO	Novo Nordisk A S This page	121,486	$5,824,038

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$5,824,038	121,486	+13.7%	Shares	Sole	2026-08-04
2026-03-31	$3,925,635	106,820	-8.7%	Shares	Sole	2026-05-13
2025-12-31	$5,954,384	117,028	-2.7%	Shares	Sole	2026-01-23
2025-09-30	$6,671,895	120,236	+1.4%	Shares	Sole	2025-11-12
2025-06-30	$8,185,841	118,601	-3.6%	Shares	Sole	2025-08-13
2025-03-31	$8,543,064	123,028	-3.9%	Shares	Sole	2025-05-06
2024-12-31	$11,007,463	127,964	+161.9%	Shares	Sole	2025-01-27
2024-09-30	$5,818,474	48,866	+9.2%	Shares	Sole	2024-11-07
2024-06-30	$6,385,902	44,738	+1133.5%	Shares	Sole	2024-08-07
2024-03-31	$465,706	3,627	+16.7%	Shares	Sole	2024-05-02
2023-12-31	$321,522	3,108	+6.7%	Shares	Sole	2024-02-05
2023-09-30	$264,999	2,914	+96.1%	Shares	Sole	2023-11-08
2023-06-30	$240,479	1,486	-1.0%	Shares	Sole	2023-08-04
2023-03-31	$238,869	1,501	—	Shares	Sole	2023-05-15
No filing history on record for this holder in this stock.